Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 1.191.221.261.211.17

What is the latest Fixed Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Fixed Capital/Sales ratio of PIRAMAL PHARMA is 1.19 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20251.19
Mar20241.22
Mar20231.26
Mar20221.21
Mar20211.17

How is Fixed Capital/Sales of PIRAMAL PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2025 1.19
-2.46
Mar2024 1.22
-3.17
Mar2023 1.26
4.13
Mar2022 1.21
3.42
Mar2021 1.17 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Fixed Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,632.7 Cr -1.9% 4.9% -17.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,054.0 Cr 0.9% 6.2% -1.3% Stock Analytics
DIVIS LABORATORIES ₹167,075.0 Cr 2% 4.8% 4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,904.0 Cr 3.6% 6% 36.9% Stock Analytics
CIPLA ₹107,358.0 Cr -0.1% -3% -8.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,813.0 Cr 1% 10.8% 4.7% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.9%

4.9%

-17.3%

SENSEX

-1.4%

0.4%

8.3%


You may also like the below Video Courses